The Indian Pharmaceutical Industry is having wide range of capabilities in the complex field of drug manufacture and technology. The country's pharmaceutical market is a US$ 7.3 billion opportunity with the domestic retail market expected to cross the US$ 10 billion mark in 2010 and be worth an estimated US$ 12-13 billion in 2012.

• The Indian pharmaceutical industry ranks 4th in terms of volume.
• In terms of value it ranks 13th and produces 20-24 % of the world's generic drugs.
• India is also one of the top five active pharmaceutical ingredients (API) producers.

The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share.
To accelerate growth in this sector the Government of India allows 100% foreign investment through the automatic route. Industrial licensing for all bulk drugs, intermediaries and formulations has been abolished. The number of drugs under price control has been reduced from 74 to 28.